Abstract

Somatostatinomas are rare neuroendocrine tumors of the gastrointestinal tract that can cause new-onset diabetes. Often the diagnosis is delayed. This case demonstrates this usual delay because the tumor was not considered for over 1 year despite a characteristic presentation. A 42-year-old man presented to his primary care physician with intermittent diarrhea and a 15-kg weight loss over 1 year. During evaluation, he was found to have diabetes mellitus and was treated with oral sulfonylurea. His diarrhea was evaluated with colonoscopy, which was normal. His symptoms persisted over another year, and he presented for a second opinion. A computed tomography scan of the abdomen was done, which showed a 3- to 4-cm mass anterior to the descending portion of the duodenum with marked atrophy of the pancreas. The patient underwent a Whipple procedure, and a 2.6-cm pancreatic endocrine neoplasm was removed, which stained positively for somatostatin, MAK6 (cytokeratin), chromogranin, and Ki-67. Lymph nodes were negative for malignancy. After surgery, his hyperglycemia resolved off all medications and his somatostatin concentration remains normal. New-onset diabetes with diarrhea, weight loss, and abdominal pain, the classic triad of somatostatinoma, should prompt consideration of secondary causes for diabetes, including pancreatic cancer or a somatostatin-producing tumor. Although somatostatinomas are extremely rare, familiarity with the characteristic symptoms, along with the greater availability of reliable radioimmunoassays, should result in an earlier diagnosis of somatostatinoma.

Original languageEnglish (US)
Pages (from-to)185-189
Number of pages5
JournalEndocrinologist
Volume14
Issue number4
DOIs
StatePublished - Jul 1 2004

Fingerprint

Somatostatinoma
Somatostatin
Diarrhea
Pancreatic Neoplasms
Weight Loss
Chromogranins
Neoplasms
Neuroendocrine Tumors
Delayed Diagnosis
Primary Care Physicians
Colonoscopy
Keratins
Duodenum
Hyperglycemia
Abdomen
Abdominal Pain
Atrophy
Radioimmunoassay
Gastrointestinal Tract
Early Diagnosis

Keywords

  • Diabetes mellitus
  • Diarrhea
  • Neuroendocrine tumor
  • Somatostatinoma
  • Weight loss

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

A case of new-onset diabetes cured with surgery. / Sulanc, Ebru; Neumeister, Amy S; Gentry, John; Thompson, Jon S; Larsen, Jennifer Lynn.

In: Endocrinologist, Vol. 14, No. 4, 01.07.2004, p. 185-189.

Research output: Contribution to journalArticle

@article{6294afe4b7e149dc983f18d331e063ca,
title = "A case of new-onset diabetes cured with surgery",
abstract = "Somatostatinomas are rare neuroendocrine tumors of the gastrointestinal tract that can cause new-onset diabetes. Often the diagnosis is delayed. This case demonstrates this usual delay because the tumor was not considered for over 1 year despite a characteristic presentation. A 42-year-old man presented to his primary care physician with intermittent diarrhea and a 15-kg weight loss over 1 year. During evaluation, he was found to have diabetes mellitus and was treated with oral sulfonylurea. His diarrhea was evaluated with colonoscopy, which was normal. His symptoms persisted over another year, and he presented for a second opinion. A computed tomography scan of the abdomen was done, which showed a 3- to 4-cm mass anterior to the descending portion of the duodenum with marked atrophy of the pancreas. The patient underwent a Whipple procedure, and a 2.6-cm pancreatic endocrine neoplasm was removed, which stained positively for somatostatin, MAK6 (cytokeratin), chromogranin, and Ki-67. Lymph nodes were negative for malignancy. After surgery, his hyperglycemia resolved off all medications and his somatostatin concentration remains normal. New-onset diabetes with diarrhea, weight loss, and abdominal pain, the classic triad of somatostatinoma, should prompt consideration of secondary causes for diabetes, including pancreatic cancer or a somatostatin-producing tumor. Although somatostatinomas are extremely rare, familiarity with the characteristic symptoms, along with the greater availability of reliable radioimmunoassays, should result in an earlier diagnosis of somatostatinoma.",
keywords = "Diabetes mellitus, Diarrhea, Neuroendocrine tumor, Somatostatinoma, Weight loss",
author = "Ebru Sulanc and Neumeister, {Amy S} and John Gentry and Thompson, {Jon S} and Larsen, {Jennifer Lynn}",
year = "2004",
month = "7",
day = "1",
doi = "10.1097/01.ten.0000134895.34295.cd",
language = "English (US)",
volume = "14",
pages = "185--189",
journal = "Endocrinologist",
issn = "1051-2144",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - A case of new-onset diabetes cured with surgery

AU - Sulanc, Ebru

AU - Neumeister, Amy S

AU - Gentry, John

AU - Thompson, Jon S

AU - Larsen, Jennifer Lynn

PY - 2004/7/1

Y1 - 2004/7/1

N2 - Somatostatinomas are rare neuroendocrine tumors of the gastrointestinal tract that can cause new-onset diabetes. Often the diagnosis is delayed. This case demonstrates this usual delay because the tumor was not considered for over 1 year despite a characteristic presentation. A 42-year-old man presented to his primary care physician with intermittent diarrhea and a 15-kg weight loss over 1 year. During evaluation, he was found to have diabetes mellitus and was treated with oral sulfonylurea. His diarrhea was evaluated with colonoscopy, which was normal. His symptoms persisted over another year, and he presented for a second opinion. A computed tomography scan of the abdomen was done, which showed a 3- to 4-cm mass anterior to the descending portion of the duodenum with marked atrophy of the pancreas. The patient underwent a Whipple procedure, and a 2.6-cm pancreatic endocrine neoplasm was removed, which stained positively for somatostatin, MAK6 (cytokeratin), chromogranin, and Ki-67. Lymph nodes were negative for malignancy. After surgery, his hyperglycemia resolved off all medications and his somatostatin concentration remains normal. New-onset diabetes with diarrhea, weight loss, and abdominal pain, the classic triad of somatostatinoma, should prompt consideration of secondary causes for diabetes, including pancreatic cancer or a somatostatin-producing tumor. Although somatostatinomas are extremely rare, familiarity with the characteristic symptoms, along with the greater availability of reliable radioimmunoassays, should result in an earlier diagnosis of somatostatinoma.

AB - Somatostatinomas are rare neuroendocrine tumors of the gastrointestinal tract that can cause new-onset diabetes. Often the diagnosis is delayed. This case demonstrates this usual delay because the tumor was not considered for over 1 year despite a characteristic presentation. A 42-year-old man presented to his primary care physician with intermittent diarrhea and a 15-kg weight loss over 1 year. During evaluation, he was found to have diabetes mellitus and was treated with oral sulfonylurea. His diarrhea was evaluated with colonoscopy, which was normal. His symptoms persisted over another year, and he presented for a second opinion. A computed tomography scan of the abdomen was done, which showed a 3- to 4-cm mass anterior to the descending portion of the duodenum with marked atrophy of the pancreas. The patient underwent a Whipple procedure, and a 2.6-cm pancreatic endocrine neoplasm was removed, which stained positively for somatostatin, MAK6 (cytokeratin), chromogranin, and Ki-67. Lymph nodes were negative for malignancy. After surgery, his hyperglycemia resolved off all medications and his somatostatin concentration remains normal. New-onset diabetes with diarrhea, weight loss, and abdominal pain, the classic triad of somatostatinoma, should prompt consideration of secondary causes for diabetes, including pancreatic cancer or a somatostatin-producing tumor. Although somatostatinomas are extremely rare, familiarity with the characteristic symptoms, along with the greater availability of reliable radioimmunoassays, should result in an earlier diagnosis of somatostatinoma.

KW - Diabetes mellitus

KW - Diarrhea

KW - Neuroendocrine tumor

KW - Somatostatinoma

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=3242686133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242686133&partnerID=8YFLogxK

U2 - 10.1097/01.ten.0000134895.34295.cd

DO - 10.1097/01.ten.0000134895.34295.cd

M3 - Article

VL - 14

SP - 185

EP - 189

JO - Endocrinologist

JF - Endocrinologist

SN - 1051-2144

IS - 4

ER -